Sign in
4

Changes in Ownership

Coherus Oncology, Inc. Filed Acc 0000899243-19-017621

Chief Financial Officer sold 6,826 shares at an average $19.85 ($135,514)

  • Chief Financial Officer acquired 3,159 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Viret Jean-Frederic · Chief Financial Officer

Table I: Non-derivative

5 lines
Date Transaction Shares Price Value Owned after D/I
2019-06-18 Sale : show line 1 in the form −3,000 $19.31 $57,926 12,180 D
2019-06-19 Sale : show line 2 in the form −667 $20.00 $13,340 11,513 D
2019-06-19 Exercise or conversion : show line 3 in the form +3,159 $10.05 $31,748 14,672 D
2019-06-19 Sale : show line 4 in the form −3,059 $20.32 $62,166 11,613 D
2019-06-19 Sale : show line 5 in the form −100 $20.81 $2,081 11,513 D
Open-market sales · 6,826 sh · avg $19.85 · $135,514

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2019-06-19 Exercise or conversion : show line 6 in the form Stock Option (Right to Buy) −3,159 126,841 D
Loading xslF345X03/doc4.xml…